# Nihon Kohden acquires 71.4% stake in Ad-Tech Medical Instrument Corporation

Nihon Kohden announced the acquisition of a 71.4% stake in NeuroAdvanced Corp., the parent company of Ad-Tech Medical Instrument Corporation, a provider of specialized electrodes for epilepsy treatment and neurodiagnostic procedures. The deal strengthens Nihon Kohden's position in neurological diagnostics.

- Type: Acquisition
- Announced: 2024-11-12
- Where: Irvine, California, United States
- Value: $103.7M
- Status: announced
- Products: intracranial electrodes, EEG systems, SEEG electrodes, brain stimulation electrodes
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ARCHIMED](https://endata.com/companies/34181.md) (partner)
- [Nihon Kohden](https://endata.com/companies/36060.md) (acquirer)
- [NeuroAdvanced Corp.](https://endata.com/companies/80916.md) (target)
- [Ad-Tech Medical Instrument Corporation](https://endata.com/companies/80917.md) (partner)
- [Ad-Tech Medical Instrument Corporation](https://endata.com/companies/80917.md) (target)
- [Ad-Tech](https://endata.com/companies/81324.md) (target)

## Sources

- [businesswire.com](https://www.businesswire.com/news/home/20241112204199/en/Nihon-Kohden-Enhances-Neurological-Treatment-Through-the-Acquisition-of-Ad-Tech-Medical-Instrument-Corporation), 2024-11-12: "Nihon Kohden, a global leader in medical device innovation for high-precision patient monitoring and diagnostics, today announced the acquisition of a 71.4% stake in NeuroAdvanced Corp., the parent company of Ad-Tech Medical Instrument Corporation."
- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/nihon-kohden-expands-neurology-portfolio-with-ad-tech-medical-acquisition/), 2024-11-13: "This acquisition represents a pivotal step in advancing critical solutions for epilepsy care."
- [latimes.com](https://www.latimes.com/b2b/industries/story/2024-11-13/ad-tech-medical-instrument-corporation-acquired-by-nihon-kohden), 2024-11-13: "The move further solidifies Nihon Kohden’s position as an industry leader by combining its established expertise in EEG systems with Ad-Tech’s specialized intracranial electrodes."
- [archimed.group](https://www.archimed.group/news/archimed-earns-5x-its-investment-selling-a-majority-of-ad-tech-to-tokyo-listed-nihon-kohden/), 2024-11-26: "This acquisition represents a pivotal step in advancing critical solutions for epilepsy care."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.